Based on these results, we evaluated the expression as well as the secretion level of inflammatory cytokines (CCL-2, IL-6, IL-8, TGF-β) in GC-MSCs pretreated with different concentrations of DIM. The gene discussed is CCL2; the disease is gastric cancer.